{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:45:09Z","timestamp":1791341109996,"version":"4.3.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":951,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.bbmt.2012.02.013","type":"journal-article","created":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T20:31:50Z","timestamp":1332275510000},"page":"1422-1429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Mobilized Peripheral Blood Stem Cells Compared with Bone Marrow as the Stem Cell Source for Unrelated Donor Allogeneic Transplantation with Reduced-Intensity Conditioning in Patients with Acute Myeloid Leukemia in Complete Remission: An Analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation"],"prefix":"10.1016","volume":"18","author":[{"given":"Arnon","family":"Nagler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Labopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avichai","family":"Shimoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietger","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam J.","family":"Mufti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel R.","family":"Zander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham H.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Craddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald W.","family":"Bunjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slawomira","family":"Kyrcz-Krzemien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2012.02.013_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0140-6736(84)92009-9","article-title":"How does bone-marrow transplantation cure leukaemia?","volume":"2","author":"Gale","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2012.02.013_bib2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.02.013_bib3","first-page":"18","article-title":"Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy","volume":"111","author":"Champlin","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib4","first-page":"242","article-title":"Nonmyeloablative stem cell transplantation: lessons from the first decade of clinical experience","volume":"3","author":"Shimoni","year":"2004","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.bbmt.2012.02.013_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.leu.2404037","article-title":"Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity","volume":"20","author":"Shimoni","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2012.02.013_bib6","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy","volume":"89","author":"Giralt","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.02.013_bib7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/14653240410005285-1","article-title":"Factors affecting engraftment of allogeneic hematopoietic stem cells after reduced-intensity conditioning","volume":"6","author":"Walshe","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2012.02.013_bib8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00277-008-0542-4","article-title":"Influence of conditioning regimens and stem cell sources on donor-type chimerism early\u00a0after stem cell transplantation","volume":"87","author":"Sugita","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.blre.2004.06.003","article-title":"Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning","volume":"19","author":"Baron","year":"2005","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2012.02.013_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.bmt.1703355","article-title":"Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT)","volume":"29","author":"Bacigalupo","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.02.013_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2141.1994.tb08321.x","article-title":"G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft","volume":"87","author":"Dreger","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib12","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1182\/blood.V86.7.2842.2842","article-title":"Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease","volume":"86","author":"K\u00f6rbling","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.02.013_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","article-title":"Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle","volume":"18","author":"Blaise","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0301-472X(03)00194-2","article-title":"Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen","volume":"31","author":"Faucher","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/10428190400014900","article-title":"CD34+ cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation","volume":"46","author":"D\u00edez-Campelo","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2012.02.013_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/shem.2002.29245","article-title":"Optimizing engraftment\u2013source and dose of stem cells","volume":"39","author":"Schmitz","year":"2002","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib17","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1200\/JCO.2001.19.16.3685","article-title":"Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis","volume":"19","author":"Cutler","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib18","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1200\/JCO.2002.12.049","article-title":"Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia","volume":"20","author":"Ringd\u00e9n","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib19","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1200\/JCO.2005.09.020","article-title":"Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials","volume":"23","author":"Stem Cell Trialists' Collaborative Group","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib20","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.02.013_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers","volume":"344","author":"Bensinger","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2012.02.013_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2001-12-0304","article-title":"Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia","volume":"100","author":"Schmitz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.02.013_bib23","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.bbmt.2007.08.006","article-title":"Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival","volume":"13","author":"Eapen","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.02.013_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1703819","article-title":"Accreditation Committee. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey","volume":"30","author":"Gratwohl","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.02.013_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/bmt.2010.69","article-title":"The EBMT activity survey 2008: impact of team size, team density and new trends","volume":"46","author":"Gratwohl","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.02.013_bib27","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/sj.leu.2403967","volume":"19","author":"Aoudjhane","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2012.02.013_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.02.013_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12185-010-0581-1","article-title":"Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry","volume":"91","author":"Nagafuji","year":"2010","journal-title":"Int J Hematol"},{"issue":"10","key":"10.1016\/j.bbmt.2012.02.013_bib30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.bmt.1701234","article-title":"Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation","volume":"21","author":"Schmitz","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.02.013_bib31","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1182\/blood-2006-05-024042","article-title":"Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation","volume":"108","author":"Schmitz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.02.013_bib32","first-page":"643","article-title":"Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial","volume":"90","author":"Schmitz","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2012.02.013_bib33","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3324\/haematol.2009.006924","article-title":"Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study","volume":"94","author":"Gallardo","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2012.02.013_bib34","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2002-01-0048","article-title":"A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies","volume":"100","author":"Couban","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.02.013_bib35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/CCO.0b013e3282f5100b","article-title":"Peripheral blood progenitor cell or bone marrow transplantation: controversy remains","volume":"20","author":"Koca","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.leu.2403591","article-title":"Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning","volume":"19","author":"Shimoni","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2012.02.013_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.beha.2008.02.006","article-title":"Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity","volume":"21","author":"Johnston","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib38","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","article-title":"Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation","volume":"102","author":"Mielcarek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.02.013_bib39","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/sj.leu.2404886","volume":"21","author":"Shimoni","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2012.02.013_bib40","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","article-title":"Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial","volume":"355","author":"Powles","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2012.02.013_bib41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","article-title":"Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial","volume":"100","author":"Flowers","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.02.013_bib42","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1182\/blood.V100.9.3128","article-title":"Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study","volume":"100","author":"Mohty","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.02.013_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbmt.2004.09.010","article-title":"Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia","volume":"11","author":"Oehler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.02.013_bib44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bmt.1704112","article-title":"Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials","volume":"32","author":"Horan","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl. 1","key":"10.1016\/j.bbmt.2012.02.013_bib45","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/01.cco.0000357474.66035.9b","article-title":"Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease","volume":"21","author":"Valc\u00e1rcel","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bbmt.2012.02.013_bib46","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1002\/cncr.25228","article-title":"Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up","volume":"116","author":"Shimoni","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2012.02.013_bib47","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.tp.0000275184.41831.6d","article-title":"Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents","volume":"84","author":"Remberger","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2012.02.013_bib48","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3324\/haematol.11353","article-title":"Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma","volume":"92","author":"Gahrton","year":"2007","journal-title":"Haematologica"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879112001115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879112001115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:42:51Z","timestamp":1761057771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879112001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1083879112001115"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.02.013","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mobilized Peripheral Blood Stem Cells Compared with Bone Marrow as the Stem Cell Source for Unrelated Donor Allogeneic Transplantation with Reduced-Intensity Conditioning in Patients with Acute Myeloid Leukemia in Complete Remission: An Analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}